| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT07208058 A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of… |
Trial sites expanded: 15 -> 18 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07715747 A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07208058 | A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of… | Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis | Recruiting |
| Phase 2/3 | |||
| NCT06984588 | A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07453004 | A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty… | Acute Gouty Arthritis | Recruiting |
| NCT07005336 | A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07715747 | A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of… | Solid Tumor | Not Yet Recruiting |